Lineage Cell Therapeutics - 6 Year Dividend History | LCTX
Historical dividend payout and yield for Lineage Cell Therapeutics (LCTX) since 2018. The current TTM dividend payout for Lineage Cell Therapeutics (LCTX) as of April 18, 2024 is $0.00. The current dividend yield for Lineage Cell Therapeutics as of April 18, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.243B |
$0.009B |
|
Lineage Cell Therapeutics Inc. is a clinical-stage biotechnology company. It focuses on developing and commercializing therapies for the treatment of degenerative diseases primarily in the United States and internationally. The company's lead product candidates include OpRegen, OPC1 and VAC2 which are in clinical stage. Lineage Cell Therapeutics Inc., formerly known as BioTime Inc., is based in Carlsbad, California.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
